4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The first concurrent detection of mitochondrial DNA m.3243A>G mutation, deletion, and depletion in a family with mitochondrial diabetes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Mitochondrial diabetes (MD) is a rare monogenic form of diabetes and divided into type l and type 2. It is characterized by a strong familial clustering of diabetes with the presence of maternal transmission in conjunction with bilateral hearing impairment in most of the carriers. The most common form of MD is associated with the m.3243A>G mutation in the mitochondrial MT‐TL1, but there are also association with a range of other point mutations, deletion, and depletion in mtDNA.

          Methods

          The mitochondrial genome anomalies were investigated in a family with clinical features of MD, which includes a proband presenting severe MD conditions including cardiomyopathy, retinopathy, and psychomotor retardation.

          Results

          By investigating the patient's blood leukocytes and skeletal muscle, we identified the m.3243A>G mutation in heteroplasmic state. This mutation was absent in the rest of the family members. In addition, our analysis revealed in the proband a large mtDNA heteroplasmic deletion (~1 kb) and a reduction in mtDNA copy number.

          Conclusion

          Our study points out, for the first time, a severe phenotypic expression of the m.3243A>G point mutation in association with mtDNA deletion and depletion in MD.

          Abstract

          Identification of de novo m.3243A>G mutation in a patient with complicated mitochondrial diabetes. This known pathogenic mutation is present with a high heteroplasmic rate and for the first time, it is associated with a large mitochondrial deletion (~1.0kb) and depletion of the mitochondrial content. So, we discuss here the correlation between these mitochondrial alterations and the severity of mitochondrial diabetes.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          Molecular understanding of hyperglycemia's adverse effects for diabetic complications.

          Diabetic complications are the major cause of morbidity and mortality in persons with diabetes. Chronic hyperglycemia is a major initiator of diabetic microvascular complications (eg, retinopathy, neuropathy, nephropathy). Glucose processing uses a variety of diverse metabolic pathways; hence, chronic hyperglycemia can induce multiple cellular changes leading to complications. Several predominant well-researched theories have been proposed to explain how hyperglycemia can produce the neural and vascular derangements that are hallmarks of diabetes. These theories can be separated into those that emphasize the toxic effects of hyperglycemia and its pathophysiological derivatives (such as oxidants, hyperosmolarity, or glycation products) on tissues directly and those that ascribe pathophysiological importance to a sustained alteration in cell signaling pathways (such as changes in phospholipids or kinases) induced by the products of glucose metabolism. This article summarizes these theories and the potential therapeutic interventions that may prevent diabetic complications in the presence of hyperglycemia, control of which is often difficult with current therapeutic options.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Automating the identification of DNA variations using quality-based fluorescence re-sequencing: analysis of the human mitochondrial genome.

            Diagnostic re-sequencing plays a central role in medical and evolutionary genetics. In this report we describe a process that applies fluorescence-based re-sequencing and an integrated set of analysis tools to automate and simplify the identification of DNA variations using the human mitochondrial genome as a model system. Two programs used in genome sequence analysis (Phred, a base-caller, and Phrap, a sequence assembler) are applied to assess the quality of each base call across the sequence. Potential DNA variants are automatically identified and 'tagged' by comparing the assembled sequence with a reference sequence. We also show that employing the Consed program to display a set of highly annotated reference sequences greatly simplifies data analysis by providing a visual database containing information on the location of the PCR primers, coding and regulatory sequences and previously known DNA variants. Among the 12 genomes sequenced 378 variants including 29 new variants were identified along with two heteroplasmic sites, automatically detected by the PolyPhred program. Overall we document the ease and speed of performing high quality and accurate fluorescence-based re-sequencing on long tracts of DNA as well as the application of new approaches to automatically find and view DNA variants among these sequences.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Mitochondrial DNA Integrity: Role in Health and Disease

              As the primary cellular location for respiration and energy production, mitochondria serve in a critical capacity to the cell. Yet, by virtue of this very function of respiration, mitochondria are subject to constant oxidative stress that can damage one of the unique features of this organelle, its distinct genome. Damage to mitochondrial DNA (mtDNA) and loss of mitochondrial genome integrity is increasingly understood to play a role in the development of both severe early-onset maladies and chronic age-related diseases. In this article, we review the processes by which mtDNA integrity is maintained, with an emphasis on the repair of oxidative DNA lesions, and the cellular consequences of diminished mitochondrial genome stability.
                Bookmark

                Author and article information

                Contributors
                mounamouna62@yahoo.fr
                Journal
                Mol Genet Genomic Med
                Mol Genet Genomic Med
                10.1002/(ISSN)2324-9269
                MGG3
                Molecular Genetics & Genomic Medicine
                John Wiley and Sons Inc. (Hoboken )
                2324-9269
                11 May 2020
                July 2020
                : 8
                : 7 ( doiID: 10.1002/mgg3.v8.7 )
                : e1292
                Affiliations
                [ 1 ] Molecular and Functional Genetics Laboratory Faculty of Science of Sfax University of Sfax Sfax Tunisia
                [ 2 ] Human Molecular Genetics Laboratory Faculty of Medicine of Sfax University of Sfax Sfax Tunisia
                [ 3 ] Department of Endocrinology Diabetology CHU Hedi Chaker Sfax Tunisia
                Author notes
                [*] [* ] Correspondence

                Mouna Tabebi, Molecular and Functional Genetics Laboratory, Faculty of Science of Sfax, University of Sfax, Route Soukra. Km 3, 3038 Sfax, Tunisia.

                Email: mounamouna62@ 123456yahoo.fr

                Author information
                https://orcid.org/0000-0002-2873-161X
                https://orcid.org/0000-0002-8420-139X
                Article
                MGG31292
                10.1002/mgg3.1292
                7336730
                32394641
                cf66e6ab-a70d-44f4-8bc7-f853c3dd28e1
                © 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 11 January 2020
                : 09 April 2020
                : 13 April 2020
                Page count
                Figures: 3, Tables: 2, Pages: 9, Words: 6230
                Funding
                Funded by: The Ministry of Higher Education and Scientific Research, Tunisia
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                July 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.5 mode:remove_FC converted:06.07.2020

                m.3243a>g mutation,mitochondrial diabetes,mitochondrial dna,mtdna deletion,mtdna depletion

                Comments

                Comment on this article